1375453-69-2Relevant articles and documents
Novel sulfonylurea derivatives as H3 receptor antagonists. Preliminary SAR studies
Ceras, Javier,Cirauqui, Nuria,Pérez-Silanes, Silvia,Aldana, Ignacio,Monge, Antonio,Galiano, Silvia
, p. 1 - 13 (2012/07/14)
The combination of antagonism at histamine H3 receptor and the stimulation of insulin secretion have been proposed as an approach to new dual therapeutic agents for the treatment of type 2 diabetes mellitus associated with obesity. We have desi